12:00 AM
 | 
Sep 17, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

TRV027: Phase I data

A Phase I trial in 20 healthy volunteers aged 18-45 who were on a low-sodium diet showed that single ascending-doses of 0.01-20 µg/kg/min IV TRV027 infused over 4 hours were well...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >